Arriving in the field of weight management management, retatrutide represents a distinct strategy. Beyond many current medications, retatrutide works as a dual agonist, simultaneously targeting both glucagon-like peptide-1 (GLP-1) and glucose-responsive here insulinotropic hormone (GIP) receptors. This dual stimulation promotes several advantageous